Filter Results
Clinical Studies
Results filtered:Study status:
Open
Closed for Enrollment
Closed for Enrollment
-
A Phase 1/2 Multi-center Study Evaluating The Safety And Efficacy Of Axicabtagene Ciloleucel In Combination With Utomilumab In Subjects With Refractory Large B-Cell Lymphoma
Rochester, MN
The purpose of this study is to evaluate the safety of axicabtagene ciloleucel in combination with utomilumab and to identify the most appropriate dose and timing of utomilumab to carry forward from Phase 1 into Phase 2, and to evaluate the effectiveness of axicabtagene ciloleucel and utomilumab in participants with refractory large B-cell lymphoma in Phase 2.
-
MC1684 Phase I Trial Of Systemic Administration Of Vesicular Stomatitis Virus Genetically Engineered To Express NIS And Human Interferon, In Patients With Relapsed Or Refractory Multiple Myeloma, Acute Myeloid Leukemia, And T-Cell Neoplasms
Scottsdale/Phoenix, AZ
This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta-sodium iodide symporter [NIS]) in treating patients with multiple myeloma, acute myeloid leukemia, or T-cell lymphoma that has come back or does not respond to treatment. A virus, called VSV-hIFNbeta-NIS, which has been changed in a certain way, may be able to kill cancer cells without damaging normal cells.
.